A Tool To Interrogate a New Class of Reactive Electrophile Drugs

In 2014, the European Medicines Agency approved the drug Tecfidera for the treatment of relapsing multiple sclerosis, a neurodegenerative disease that affects millions of people...
The post A Tool To Interrogate a New Class of Reactive Electrophile Drugs appeared first on SciTechDaily.